{"id":7297,"date":"2026-01-26T01:15:14","date_gmt":"2026-01-26T09:15:14","guid":{"rendered":"http:\/\/pandapeptides.com\/product\/cjc-1295-with-dac\/"},"modified":"2026-04-07T19:06:00","modified_gmt":"2026-04-08T02:06:00","slug":"cjc-1295-with-dac","status":"publish","type":"product","link":"https:\/\/pandapeptides.com\/es\/producto\/cjc-1295-with-dac\/","title":{"rendered":"CJC-1295 (WITH DAC)"},"content":{"rendered":"
\n

CJC-1295 with DAC<\/strong> is a modified growth hormone-releasing hormone analog (tetrasubstituted GRF 1-29) conjugated to Drug Affinity Complex (DAC) via a lysine linker. CAS 863288-34-0, molecular weight ~3647 Da. The DAC moiety enables albumin binding, extending plasma half-life to approximately 6-8 days in research models. Research compound \u2014 for laboratory use only.<\/em><\/p>\n<\/div>\n

CJC-1295 with DAC<\/h2>\n

Long-Acting GHRH Analog \u2014 For Research Use Only<\/strong><\/p>\n

\n

CJC-1295 with DAC<\/strong> is a modified GHRH(1-29) analog conjugated to a Drug Affinity Complex (maleimidopropionic acid\u2013lysine linker) that enables covalent binding to serum albumin. The base peptide has CAS 863288-34-0. The DAC modification extends the half-life to approximately 6\u20138 days by preventing renal clearance. Molecular weight approximately 3647 Da (peptide + linker). Research compound \u2014 for laboratory use only.<\/em><\/p>\n<\/div>\n

Product Details<\/h3>\n